AstraZeneca sells Seroquel rights for $538m
10-05-2018
UK government announces life sciences deal; GSK and AstraZeneca invest
11-12-2017
AstraZeneca forms Chinese company to boost innovation
28-11-2017
miodrag ignjatovic / iStockphoto.com
AstraZeneca has sold the US rights and New Drug Applications to four drugs to ANI Pharmaceuticals, a speciality pharmaceutical company.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
AstraZeneca, rights, pharmaceuticals, ANI Pharmaceuticals, licence, royalties, hypertension, cancer
